Patent details

EP3233104 Title: IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS

Basic Information

Publication number:
EP3233104
PCT Application Number:
US2015066400
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158710756
PCT Publication Number:
WO2016100679
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS
French Title of Invention:
TRAITEMENTS ET COMPOSITIONS D'IMMUNOTHÉRAPIE
German Title of Invention:
IMMUNTHERAPIEBEHANDLUNGEN UND ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
17/12/2015
Grant date:
04/03/2020
EP Publication Date:
25/10/2017
PCT Publication Date:
23/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/03/2020
EP B1 Publication Date:
04/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2020
Expiration date:
17/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/02/2020
 
 

Name:
Susavion Biosciences, Inc.
Address:
1615 W. University Drive, Suite 132, Tempe, AZ 85281, United States (US)

Inventor

1

Name:
EGGINK, Laura L.
Address:
United States (US)

2

Name:
HOOBER, J. Kenneth
Address:
United States (US)

Priority

Priority Number:
201462094944 P
Priority Date:
19/12/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/00; A61K 38/10; A61K 39/00; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202010
Publication date:
04/03/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages